Share on Facebook Share on Twitter Email
Answers.com

Dihydrofolate reductase inhibitor

 
Wikipedia: Dihydrofolate reductase inhibitor

A dihydrofolate reductase inhibitor is a molecule that inhibits the function of dihydrofolate reductase, and is a type of antifolate.

Since folate is needed by rapidly dividing cells to make thymine, this effect may be used to therapeutic advantage. For example, methotrexate is used as cancer chemotherapy because it can prevent neoplastic cells from dividing.[1][2] Bacteria also need DHFR to grow and multiply and hence inhibitors selective for bacterial vs. host DHFR have found application as antibacterial agents.[3]

Tetrahydrofolate synthesis pathway

A variety of drugs act as inhibitors of dihydrofolate reductase:

References

  1. ^ Huennekens FM (1994). "The methotrexate story: a paradigm for development of cancer chemotherapeutic agents". Adv. Enzyme Regul. 34: 397–419. doi:10.1016/0065-2571(94)90025-6. PMID 7942284. 
  2. ^ McGuire JJ (2003). "Anticancer antifolates: current status and future directions". Curr. Pharm. Des. 9 (31): 2593–613. doi:10.2174/1381612033453712. PMID 14529544. 
  3. ^ Hawser S, Lociuro S, Islam K (March 2006). "Dihydrofolate reductase inhibitors as antibacterial agents". Biochem. Pharmacol. 71 (7): 941–8. doi:10.1016/j.bcp.2005.10.052. PMID 16359642. 
  4. ^ Mui EJ, Schiehser GA, Milhous WK, et al. (2008). "Novel Triazine JPC-2067-B Inhibits Toxoplasma gondii In Vitro and In Vivo". PLoS Negl Trop Dis 2 (3): e190. doi:10.1371/journal.pntd.0000190. PMID 18320016. 



Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
 
 

 

Copyrights:

Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Dihydrofolate reductase inhibitor" Read more